Nu Skin Enterprises Inc (NUS)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 478,040 362,896 367,753 372,609 377,466 382,323 387,179 258,995 268,781 278,563 288,343 298,120 305,393 312,664 319,932 327,197 334,461 341,724 348,986 356,247
Total stockholders’ equity US$ in thousands 821,968 822,187 895,345 892,970 897,296 841,934 941,035 934,200 912,772 936,477 917,826 871,474 894,271 827,473 792,012 800,498 875,289 845,800 834,950 811,195
Debt-to-capital ratio 0.37 0.31 0.29 0.29 0.30 0.31 0.29 0.22 0.23 0.23 0.24 0.25 0.25 0.27 0.29 0.29 0.28 0.29 0.29 0.31

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $478,040K ÷ ($478,040K + $821,968K)
= 0.37

The debt-to-capital ratio of Nu Skin Enterprises, Inc. has been relatively stable over the past eight quarters, ranging from 0.28 to 0.38. This ratio indicates the proportion of the company's capital structure that is financed by debt.

In Q1 2022, the debt-to-capital ratio was at its lowest point of 0.28, suggesting a lower reliance on debt to fund the company's operations and growth. However, this ratio increased gradually in subsequent quarters, reaching a peak of 0.38 in Q4 2023.

Overall, the trend in Nu Skin Enterprises' debt-to-capital ratio indicates a moderate level of leverage in its capital structure. The company appears to have a balanced approach to financing its operations, with a mix of debt and equity funding.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-capital ratio
Nu Skin Enterprises Inc
NUS
0.37
Cardinal Health Inc
CAH
Cencora Inc.
COR
0.82
McKesson Corporation
MCK